quinoxalines has been researched along with nintedanib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammar, R; Cai, H; Huang, X; Jarai, G; Ravi, K; Thompson, J; Wang, Y; Zhang, Y | 1 |
| Banjanac, M; Belamarić, D; Bosnar, M; Cedilak, M; Čužić, S; Eraković Haber, V; Faraho, I; Glojnarić, I; Ilić, K; Paravić Radičević, A | 1 |
2 other study(ies) available for quinoxalines and nintedanib
| Article | Year |
|---|---|
Molecular characterization of a precision-cut rat liver slice model for the evaluation of antifibrotic compounds.
Topics: Animals; Biomarkers; Collagen Type I; Imidazoles; Indoles; Liver; Liver Cirrhosis; Male; Quinoxalines; Rats, Sprague-Dawley | 2019 |
Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis.
Topics: Animals; Bleomycin; Disease Models, Animal; Idiopathic Pulmonary Fibrosis; Imidazoles; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Quinoxalines | 2019 |